🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/TZ-2026-067Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Tirzepatide 30 mg

TZ-2026-067Lot 20-10-02Analyzed November 14, 2026

Timeline

Ordered
October 25, 2026
Received
November 13, 2026
Analyzed
November 14, 2026

Sample

Name
Tirzepatide 30 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder

Testing

Client
SALT Peptides
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
30.50mg
Label claim: 30 mg
Purity, how clean it is
99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold.

Chromatogram

HPLC-UV

mAU-10001002003000481216202428Retention time (min)19.01
19.01 min, Tirzepatide, 99.9%

Analyst Comments

White lyophilized powder, green-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 14, 2026

Verification Code

TZ-31B2-QGF9
Verify at purilab.org/verify/TZ-31B2-QGF9

Scan to Verify

TZ-31B2-QGF9

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1